Full Text View
Tabular View
No Study Results Posted
Related Studies
Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes
This study has been withdrawn prior to enrollment.
( Slow accrual. )
Study NCT00038870   Information provided by M.D. Anderson Cancer Center

First Received on June 5, 2002.   Last Updated on August 2, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Myelogenous Leukemia
Chronic Myelogenous Leukemia
Additional conditions recognized in this trial
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myeloid
Leukemia, Myeloid, Acute
More general conditions related to this trial
Bone Marrow Diseases
Hematologic Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Dendritic Cell Activated Lymphocyte
Sponsors listed in this trial
M.D. Anderson Cancer Center
Immunex Corporation
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services